Plavsic Mark 4
4 · Aura Biosciences, Inc. · Filed Oct 16, 2025
Insider Transaction Report
Form 4
Plavsic Mark
Chief Technology Officer
Transactions
- Sale
Common Stock
2025-10-16$6.35/sh−12,169$77,273→ 197,287 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.